Cost-effectiveness of a nurse-based intervention (AIMS) to improve adherence among HIV-infected patients: design of a multi-centre randomised controlled trial

被引:5
|
作者
Oberje, Edwin [1 ]
de Bruin, Marijn [1 ]
Evers, Silvia [2 ]
Viechtbauer, Wolfgang [3 ]
Nobel, Hans-Erik [4 ]
Schaalma, Herman [5 ]
McCambridge, Jim [6 ]
Gras, Luuk [7 ]
Tousset, Eric [8 ]
Prins, Jan [4 ]
机构
[1] Univ Amsterdam, Amsterdam Sch Commun Res ASCoR, Dept Commun, NL-1012 CX Amsterdam, Netherlands
[2] Maastricht Univ, Res Sch Publ Hlth & Primary Care, Dept Hlth Serv Res, Caphri, Maastricht, Netherlands
[3] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Ctr Infect & Immun Amsterdam,Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands
[5] Maastricht Univ, Dept Work & Social Psychol, Maastricht, Netherlands
[6] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1E 7HT, England
[7] Stichting HIV Monitoring, Amsterdam, Netherlands
[8] AARDEX Grp Ltd, Vise, Belgium
关键词
Adherence; AIMS; Economic evaluation; HIV; Intervention; Randomised controlled trial; ACTIVE ANTIRETROVIRAL THERAPY; VIRAL LOAD; HEALTH; HAART; IMPLEMENTATION; NONADHERENCE; REGIMENS; OUTCOMES; COHORT;
D O I
10.1186/1472-6963-13-274
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Non-adherence to HIV-treatment can have a negative impact on patients' treatment success rates, quality of life, infectiousness, and life expectancy. Few adherence interventions have shown positive effects on adherence and/or virologic outcomes. The theory-and evidence-based Adherence Improving self-Management Strategy (AIMS) is an intervention that has been demonstrated to improve adherence and viral suppression rates in a randomised controlled trial. However, evidence of its cost-effectiveness is lacking. Following a recent review suggesting that cost-effectiveness evaluations of adherence interventions for chronic diseases are rare, and that the methodology of such evaluations is poorly described in the literature, this manuscript presents the study protocol for a multi-centre trial evaluating the effectiveness and cost-effectiveness of AIMS among a heterogeneous sample of patients. Methods/design: The study uses a multi-centre randomised controlled trial design to compare the AIMS intervention to usual care from a societal perspective. Embedded in this RCT is a trial-based and model-based economic evaluation. A planned number of 230 HIV-infected patients are randomised to receive either AIMS or usual care. The relevant outcomes include changes in adherence, plasma viral load, quality of life, and societal costs. The time horizon for the trial-based economic evaluation is 12-15 months. Costs and effects are extrapolated to a lifetime horizon for the model-based economic evaluation. Discussion: The present multicentre RCT is designed to provide sound methodological evidence regarding the effectiveness and cost-effectiveness of a nurse-based counselling intervention (AIMS) to support treatment adherence among a large and heterogeneous sample of HIV-infected patients in the Netherlands. The objective of the current paper is to describe the trial protocol in sufficient detail to allow full evaluation of the quality of the study design. It is anticipated that, if proven cost-effective, AIMS can contribute to improved evidence-based counselling guidelines for HIV-nurses and other health care professionals.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The efficacy and cost-effectiveness of a family-based economic empowerment intervention (Suubi plus Adherence) on suppression of HIV viral loads among adolescents living with HIV: results from a Cluster Randomized Controlled Trial in southern Uganda
    Tozan, Yesim
    Capasso, Ariadna
    Sun, Sicong
    Neilands, Torsten B.
    Damulira, Christopher
    Namuwonge, Flavia
    Nakigozi, Gertrude
    Mwebembezi, Abel
    Mukasa, Barbara
    Bahar, Ozge Sensoy
    Nabunya, Proscovia
    Mellins, Claude A.
    McKay, Mary M.
    Ssewamala, Fred M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 (06)
  • [32] A mobile phone intervention to reduce binge drinking among disadvantaged men: study protocol for a randomised controlled cost-effectiveness trial
    Crombie, Iain K.
    Irvine, Linda
    Williams, Brian
    Sniehotta, Falko F.
    Petrie, Dennis
    Evans, Josie M. M.
    Emslie, Carol
    Jones, Claire
    Ricketts, Ian W.
    Humphris, Gerry
    Norrie, John
    Rice, Peter
    Slane, Peter W.
    TRIALS, 2014, 15
  • [33] Evaluation of the “Let’s Get Organized” group intervention to improve time management: protocol for a multi-centre randomised controlled trial
    Marie Holmefur
    Afsaneh Roshanay
    Suzanne White
    Gunnel Janeslätt
    Elin Vimefall
    Kajsa Lidström-Holmqvist
    Trials, 22
  • [34] Cost-effectiveness of a lifestyle intervention for people with a serious mental illness (SMILE): design of a pragmatic cluster-randomised controlled trial
    Walburg, Florine S.
    van Meijel, Berno
    van Tulder, Maurits W.
    Adriaanse, Marcel C.
    BMC PSYCHIATRY, 2019, 19 (1)
  • [35] A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease
    Lock, Kevin
    Wilson, Koo
    Murphy, Daniel
    Antonio Riesco, Juan
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (17) : 2613 - 2626
  • [36] Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: A randomized controlled trial
    Zwikker, Hanneke E.
    van den Ende, Cornelia H.
    van Lankveld, Wim G.
    den Broeder, Alfons A.
    van den Hoogen, Frank H.
    van de Mosselaar, Birgit
    van Dulmen, Sandra
    van den Bemt, Bart J.
    PATIENT EDUCATION AND COUNSELING, 2014, 94 (03) : 356 - 361
  • [37] The Early Youth Engagement in first episode psychosis (EYE-2) study: pragmatic cluster randomised controlled trial of implementation, effectiveness and cost-effectiveness of a team-based motivational engagement intervention to improve engagement
    Greenwood, Kathryn
    Webb, Rebecca
    Gu, Jenny
    Fowler, David
    de Visser, Richard
    Bremner, Stephen
    Abramowicz, Iga
    Perry, Nicky
    Clark, Stuart
    O'Donnell, Anastacia
    Charlton, Dan
    Jarvis, Rebecca
    Garety, Philippa
    Nandha, Sunil
    Lennox, Belinda
    Johns, Louise
    Rathod, Shanaya
    Phiri, Peter
    French, Paul
    Law, Heather
    Hodgekins, Jo
    Painter, Michelle
    Treise, Cate
    Plaistow, James
    Irwin, Francis
    Thompson, Rose
    Mackay, Tanya
    May, Carl R.
    Healey, Andy
    Hooper, Richard
    Peters, Emmanuelle
    TRIALS, 2021, 22 (01)
  • [38] Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial
    Ising, H. K.
    Smit, F.
    Veling, W.
    Rietdijk, J.
    Dragt, S.
    Klaassen, R. M. C.
    Savelsberg, N. S. P.
    Boonstra, N.
    Nieman, D. H.
    Linszen, D. H.
    Wunderink, L.
    van der Gaag, M.
    PSYCHOLOGICAL MEDICINE, 2015, 45 (07) : 1435 - 1446
  • [39] Effectiveness and cost-effectiveness of a virtual community of practice to improve the empowerment of patients with ischaemic heart disease: study protocol of a randomised controlled trial
    Gonzalez-Gonzalez, Ana Isabel
    Perestelo-Perez, Lilisbeth
    Koatz, Debora
    Ballester, Marta
    Pacheco-Huergo, Valeria
    Ramos-Garcia, Vanesa
    Torres-Castano, Alezandra
    Rivero-Santana, Amado
    Toledo-Chavarri, Ana
    Valcarcel-Nazco, Cristina
    Mateos-Rodilla, Juana
    Obaya-Rebollar, Juan Carlos
    Garcia-Garcia, Javier
    Diaz-Sanchez, Santiago
    Morales-Cobos, Luis
    Bosch-Fontcuberta, Josep Maria
    Vallejo-Camazon, Nuria
    Rodriguez-Almodovar, Ana
    del Castillo, Jose Carlos
    Munoz-Balsa, Marcos
    del Rey-Granado, Yolanda
    Garrido-Elustondo, Sofia
    Tello-Bernabe, Maria-Eugenia
    Ramirez-Puerta, Ana Belen
    Orrego, Carola
    BMJ OPEN, 2020, 10 (10):
  • [40] DTEXT - text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis
    Waller, Karen
    Furber, Susan
    Bauman, Adrian
    Allman-Farinelli, Margaret
    van den Dolder, Paul
    Hayes, Alison
    Facci, Franca
    Franco, Lisa
    Webb, Alison
    Moses, Robert
    Colagiuri, Stephen
    BMC PUBLIC HEALTH, 2019, 19 (1)